Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02498951
Title Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors OHSU Knight Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado RECRUITING Denver Colorado 80217-3364 United States Details
Piedmont Hospital RECRUITING Atlanta Georgia 30309 United States Details
University of Michigan Comprehensive Cancer Center RECRUITING Ann Arbor Michigan 48109 United States Details
Wake Forest University Health Sciences RECRUITING Winston-Salem North Carolina 27157 United States Details
Cleveland Clinic Cancer Center/Fairview Hospital RECRUITING Cleveland Ohio 44111 United States Details
Providence Portland Medical Center RECRUITING Portland Oregon 97213 United States Details
OHSU Knight Cancer Institute RECRUITING Portland Oregon 97239 United States Details
Penn State Milton S Hershey Medical Center RECRUITING Hershey Pennsylvania 17033-0850 United States Details
Rhode Island Hospital RECRUITING Providence Rhode Island 02903 United States Details
UT Southwestern/Simmons Cancer Center-Dallas ACTIVE_NOT_RECRUITING Dallas Texas 75390 United States Details
University of Vermont Medical Center RECRUITING Burlington Vermont 05401 United States Details
University of Virginia Cancer Center RECRUITING Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field